Goorma ayaa Wajiga 1aad Daraasadaha Daawada Kediska ah ee Kansarka?
Haddii aad tixgelinayso wajiga 1aad ee kiliinikada, waa maxay macnaha dhabta ah? Sidee tani u kala duwan tahay wejiyada kale ee tijaabada caafimaadka? Iyadoo horumarinta dhawaanahan ee daaweynta kansarka, doorka wajiga 1aad ee kiliinikada ayaa noqonaya mid muhiim ah. Inkastoo marxaladan tijaabooyinka laga yaabo in loo maleynayo inay yihiin "dadaaladii ugu dambeeyey", waxaa jira dad badan oo ka badbaaday kansarka sababtoo ah jiritaanka tijaabooyinkan.
Aynu eegno wajiga 1aad ee kiliinikada tijaabada ah ee gudaha cilmi-baarista casriga ah iyo ka doodista sababta maxsuulka 1aad ee kiliinikada ah uusan noqon "halis" sidii hore.
Maskaxda ku hay in ujeedada tijaabooyinka kiliinikada ay tahay in la helo daweyno in ay ka shaqeyn karaan ama ka yaryihiin waxyeelo ka yar daawooyinka aan hada haysanno. Dhammaan daawooyinka loo isticmaalo in lagu daaweeyo kansarka ayaa markii hore la baaray iyada oo qayb ka ah tijaabo caafimaad. Wakhtigaas, dadka kaliya ee awooday in ay qaataan waxtarka daaweyntani waxay ahaayeen kuwa ku jiray kooxda daraasadda tijaabada ah.
Qeexidda iyo Ujeeddada Marxaladda 1aad ee Dacwooyinka Daaweynta
Wejiyada 1aad ee bukaan-socodka ayaa loo sameeyaa si loo eego haddii daroogada tijaabada ah ama daaweynta ay tahay mid amaan ah. Ka dib markii daaweyn lagu baaro shaybaarka ama xayawaanka, waxay gasho wajiga 1aad ee kiliinikada ee lagu sameeyo bini-aadanka. Dhibaatooyinkaasi waxay badanaa ku lug leeyihiin tiro yar oo dadka ah si ay u go'aamiyaan in dawo ama daaweyn ay tahay mid ammaan ah iyo in la go'aamiyo qiyaasta ugu fiican ee daroogada iyo sida loo bixiyo (ha ahaato hadal ama xidid).
Inkastoo ujeedada ugu muhiimsan ee tijaabooyinkani ay tahay in la qiimeeyo amniga, waxay sidoo kale go'aamin karaan in daaweyntu u muuqato in ay u shaqeyso kansar.
Wajiyada kale
Waxaa jira saddex waji oo tijaabo ah oo ay tahay in la dhameeyo ka hor inta aan daroogada loo ogolaanin FDA. Haddii daaweyntu u muuqato mid ammaan ah dhamaadka wajiga 1aad ee kiliinikada, waxa laga yaabaa inay galaan marxaladda 2aad ee kiliinikada, daraasad loo sameeyay si loo arko haddii daaweyntu ay wax ku ool tahay.
Haddii daroogada ama daaweynta loo arko inay tahay mid ammaan ah marxaladda 1aad ee maxkamadaynta iyo wax ku ool ah wajiga labaad 2, waxay markaas gali doontaa marxaladda 3 marxaladood ee kiliinikada. Marxaladda 3aad ee kiliinikada ayaa ah mid aad u ballaaran waxaana loo sameeyaa si loo arko haddii daaweyntu aysan aheyn mid ammaan ah oo wax ku ool ah laakiin waxay ka shaqeyneysaa ama saameyn yar oo ka yar daaweynta hadda la heli karo.
Wejiga 1aad ee tijaabooyinka isbeddelka tobankii sano ee la soo dhaafay
Wajiga 1aad ee tijaabooyinka, iyo waxa aad filan karto haddii aad isku qorto, aad ayay isbedeshay sanadihii ugu dambeeyay. Qaar badan oo ka mid ah dawooyinka cusub ee la baaro sannadka 2018 ayaa si taxadar leh loogu qoondeeyay inay ku shaqeeyaan jidka saxda ah ee koritaanka kansarka. Ma aha oo kaliya daawooyinka sida kuwa badanaa waxay u badantahay in ay yeeshaan saameyno waaweyn oo ka yimaada daawooyinka kiimiko ah ee daaweynta dabiiciga ah (inkastoo ay awoodaan), laakiin ku salaysan naqshad waxaa jira fursad aad u macquul ah oo ay wax ka tarayaan kansarkaaga. Dhamaantiis, haddii aad joojin karto tallaabo cayiman oo ah in kansarku u dhex maro si loo kala qaybiyo (oo markaa koraan oo faafo), waxaa jira fursado macquul ah oo kansar loo muujiyay in uu ku tiirsan yahay tallaabadaasi jawaab celin doonto.
Xaaladaha noocaas ah waxay noqon kartaa in fursadaha kaliya ee lagu daaweynayo kansarku ay noqdaan daawooyin kiimiko ah oo caadi ah. Daroogada sida daroogooyinka la bartilmaameedsaday ayaa badanaa u badan inay qabtaan kansarka baaritaanka muddo wakhti ah, iyo daawooyinka immunotherapy, ee boqolkiiba dadka ugu yaraan, waxay keeni karaan jawaab celin joogto ah (jawaab muddo dheer socota).
Iyadoo horumarka daawada saxda ah, waxay u badan tahay in tijaabooyinka wajiga 1aad ee daaweynta ay sii wadi doonaan inay bixiyaan balanqaad badan oo loogu talagalay shakhsiyaadka halkii laga yaabo inay tijaabiyaan si ay u arkaan haddii daroogadu amaan tahay.
Fikradaha Marka Lagu Qabanayo Wejiga 1 Baadhitaanka Daaweynta
Waxaa jira sababo yar oo qof laga yaabo inuu kaqaybqaato ka qaybgalka wajiga 1aad ee kiliinikada. Mid ayaa ah rajada horumarinta cilmi-baarista oo dadka kale ku caawin karta mustaqbalka. Mid kale waa rajada ah in daroogo cusub ama nidaam aan wali lagu tijaabin bini'aadamka ay bixin doonaan fursad ah badbaadin marka daaweyn kale oo ay ku fashilmeen. Habka keliya ee lagu hormarin karo daaweynta kansarka, iyo badbaadada dambe, ayaa la sameeyaa, iyada oo loo marayo ka qaybqaadashada bukaanka ee tijaabooyinka bukaan socodka.
Taasi waxay tidhi, tijaabooyinka kiliinikada maahan qof walba.
Khatarta iyo Dheefaha
Waxaa muhiim ah in la tixgeliyo dhamaan halista iyo faa'iidooyinka tijaabada bukaan-socodka haddii aad ka fekereyso mid ka mid ah daraasaddan. Had iyo jeer way fiican tahay in la qoro labadaba faa'iidooyinka iyo khasaarooyinka daraasaddan ku saabsan xaashida xaashida si aad u fahmi karto fursadahaaga. Ma jiro doorasho sax ah ama khalad ah, kaliya doorashada ku habboon ama khaldan.
Fursadaha Kale ee Lagu Helo Daroogooyinka Aaminsan
Inta badan, habka kaliya ee aad u isticmaali karto daroogo tijaabo ah (baaritaan) ayaa ah inaad ka qayb qaadato tijaabada caafimaadka. Tani mar kasta ma aha kiiska, dadka qaarkoodna waxay u qalmi karaan isticmaalka naxariis leh ama ballaarinta helitaanka daroogooyinka aan weli ogolaanin FDA. Haddii aadan u qalmin tijaabo daaweyn laakiin daawada baaritaanka ayaa u muuqata mid rajo leh kansarkaaga gaarka ah, qaado waqti aad ku barato isticmaalka daroogada naxariista leh .
Khadka hoose
Wajiyada 1aad ee tijaabada caafimaadka waa daraasadaha caafimaadka ee ugu horreeya ee daroogada ama nidaamka lagu baaro dadka. Inkasta oo caado ahaantani ay walwal ku abuurtay walbahaarkana waxay keentay in ay kaftamaan in ay noqdaan doofaarka guinea, daraasaddan koowaad waxaa loo eegi karaa siyaabo kala duwan. Laga soo bilaabo hal dhinac waxay noqon karaan kuwo khatar badan. Ka dib, ujeedada ugu muhiimsan ee tijaabooyinkan waa in la go'aamiyo in daroogadu ay amaan u tahay dadka (iyo sidoo kale inay helaan fikrad ku saabsan qiyaasta ugu fiican ee la isticmaalo).
Hase yeeshee, laga bilaabo xagal kala duwan, marxaladda koowaad ee kiliiniga 1aad waxaa laga yaabaa in wax dheeraad ah la siiyo. Marxalado badan oo tijaabooyin ah 3 tijaabo oo daaweyn ah ayaa barbardhigaya daroogooyinka horeba loo eegay. Rajada waxay noqon kartaa in daroogadu ay hagaajin doonto badbaadada haddii dhawr bilood oo keliya. Si kastaba ha ahaatee, marxaladda 1aad ee kiliinikada tijaabada, si kastaba ha ahaatee, daroogo cusub (iyo laga yaabo inay tahay nooc cusub oo daroogo ah) ayaa la eegayaa kuwaas oo laga yaabo ama aysan caawin karin, laakiin waxaa laga yaabaa in ay ka caawiso wax ka badan wixii kale ee la heli karo. Tusaalooyinka tani waxay ahaayeen kuwo soo noqnoqonayey sannadihii la soo dhaafay. Maaddaama walwalka wali ku saabsanyahay ka qayb qaadashada tijaabooyinka bukaan socod eegtada, qaado waqti aad ku barato khuraafaadka ku saabsan tijaabooyinka bukaan-socodka iyo waxa xaqiiqda iyo sheekooyinka.
> Ilo:
> Maamulka Cuntada iyo Dawooyinka Mareykanka. Nidaamka Dib u Eegista Daawada ee FDA: Diidmada Daroogadu waa Amaan oo wax ku ool ah.